Akebia Therapeutics (NASDAQ:AKBA) Upgraded by Leerink Partnrs to “Strong-Buy” Rating
Leerink Partnrs upgraded shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) to a strong-buy rating in a report published on Monday morning,Zacks.com reports. A number of other equities analysts have also commented on the stock. HC Wainwright reissued a “buy” rating and issued a $7.50 price target on shares of Akebia Therapeutics in a report […]
Leerink Partnrs upgraded shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) to a strong-buy rating in a report published on Monday morning,Zacks.com reports. A number of other equities analysts have also commented on the stock. HC Wainwright reissued a “buy” rating and issued a $7.50 price target on shares of Akebia Therapeutics in a report […]
